PolyMedic, Inc. (OTCBB: PYMX) $85M (MarketCap) Successfully Completes Phase 1B Clinical Study
(Thu Jun 3rd, 2010, by World Market Media)
PolyMedix, Inc. (OTCBB: PYMX) is an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases. Today, it announced its successful completion of a second P... |